Skip to main content

Table 1 Basic clinical characteristics of rs2241057 genotypes in the SCARF cohort.

From: A CYP26B1 Polymorphism Enhances Retinoic Acid Catabolism and May Aggravate Atherosclerosis

   Homozygous for the major allele Carriers of the minor allele
   n   n   P
Age (years)      
  Patients 282 53.0 (49.0–57.0) 90 54.0 (48.8–57.0) 0.45
  Controls 282 54.0 (49.8–57.0) 99 54.0 (49.0–57.0) 0.35
Body mass index (kg/m2)      
  Patients 281 26.8 (24.7–29.6) 90 26.6 (24.3–29.5) 0.70
  Controls 282 25.6 (23.5–27.8) 98 25.7 (24.1–27.5) 0.79
Current smokers (%)      
  Patients 282 50.7 90 51.1 0.52
  Controls 280 24.3 98 24.5 0.53
Serum cholesterol (mmol/L)      
  Patients 280 5.0 (4.2–5.7) 90 5.2 (4.5–5.7) 0.12
  Controls 282 5.4 (4.8–6.1) 99 5.5 (4.7–6.2) 0.50
Serum low-density      
  lipoprotein (mmol/L) Patients 272 3.2 (2.5–3.9) 84 3.2 (2.6–3.9) 0.33
  Controls 281 3.4 (2.9–4.1) 98 3.7 (3.0–4.3) 0.18
Serum high-density lipoprotein (mmol/L)      
  Patients 272 1.1 (0.9–1.4) 84 1.1 (0.9–1.4) 0.36
  Controls 281 1.3 (1.1–1.7) 98 1.4 (1.1–1.6) 0.58
Serum triglycerides (mmol/L)      
  Patients 280 1.6 (1.2–2.2) 90 1.6 (1.2–2.3) 0.88
  Controls 282 1.2 (0.86–1.6) 99 1.2 (0.82–1.5) 0.86
Blood CRP (mg/L)      
  Patients 272 1.39 (0.72–3.19) 88 2.01 (0.74–4.08) 0.18
  Controls 275 0.93 (0.51–1.78) 98 1.04 (0.56–2.03) 0.35
  1. Values are medians (interquartile range) or percentage (%) as indicated. CRP C-reactive protein.